Opens in a new tab

The SeqOne Genomic Analysis Platform

SeqOne is an in vitro diagnostic platform for genetic analysis, designed to help healthcare professionals interpret next-generation sequencing (NGS) and array CGH data. The platform provides qualitative and actionable results, functioning as a clinical decision support system.

Key features

It is an in vitro diagnostic medical device, Class C with CE-IVD marking and certified according to the IVDR Regulation, which ensures compliance with the highest quality and safety standards.

Its universal compatibility allows it to integrate seamlessly with any sequencer and laboratory process, advancedly optimizing the genomic workflow and improving efficiency at every stage of the analysis. With clinical validation and integration with recognized databases, SeqOne guarantees accurate and reliable diagnoses.

Furthermore, its powerful Artificial Intelligence (DiagAI) prioritizes genetic variants, facilitating the analysis and diagnosis of multiple genetic-based pathologies. Security is a priority, which is why it features a patented double encryption system and servers certified with ISO 27001 and HDS, ensuring maximum protection of patient data.

SeqOne Coverage

Clinical applications

The SeqOne genomic data tool allows healthcare professionals to have a solution that optimizes workflows and transforms complex data into clear, actionable results, with the security and confidence of having the highest standards of quality and data protection.

It facilitates informed clinical decision-making, improving efficiency in laboratories and optimizing patient care in medical areas as diverse as rare diseases, cardiology, neurology, psychiatry, carrier screening, and hereditary cancer, among many others.

SeqOne Gene Analysis

Benefits

The platform stands out for its workflow automation: it offers the possibility to automate processes, enabling fast transfers, effortless exports, and unlimited computational power.

The true optimization of the analysis lies in its AI-driven tools, which drastically accelerate variant interpretation:

DiagAI: Automatically identifies 96% of diagnostic variants. SmartPick: Instantly highlights the most likely variant, with a specificity of 92%.
SeqOne Workflow

Intended audience/user

Software solution designed for healthcare professionals and diagnostic laboratories looking to optimize the interpretation of genetic data, especially in the areas of rare diseases, hereditary disorders, carrier screening, and hereditary cancer.

SeqOne Interface

Key Features

Full integration with NGS and array-CGH data, as well as universal compatibility with any sequencer and laboratory process.
AI optimization, accelerating analysis to obtain accurate results quickly and explained for informed decision-making.
Advanced modules that allow secondary analysis from FASTQ, as well as tertiary analysis from VCF and aCGH.
Ability to perform family analyses, which are essential for a better diagnosis of hereditary diseases.
Strict regulatory compliance, including CE-IVD marking and ISO 13485 certification ensuring quality and safety in the clinical environment.
Cloud computing power that allows the processing of large volumes of data without collapsing the hospital’s infrastructure.

Area:

Molecular Genetics, Software, Software solutions for germline analysis

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

FUSIONPlex™ Heme v3 & Pan-Heme v2

RNA-based next-generation sequencing solution for the analytically sensitive identification of known and novel gene fusions, splicing variants, exon-skipping events, SNVs/Indels and gene expression in haematological malignancy research. FUSIONPlex Pan-Heme v2 provides broad coverage of 218 genes associated with haematological malignancies, while FUSIONPlex Heme v3 provides more focused coverage of 121 genes targeting alterations frequently found…
Archer Dx
Next Generation Sequencing (NGS)

Tapestri™

The Tapestri® platform enables the simultaneous integration of three biological dimensions from the same individual cell: DNA, RNA and surface proteins. This unprecedented multi-omics capability provides a direct and functional view of how specific genetic alterations (genotype) shape transcriptional expression and protein behaviour (phenotype), without the need to reconcile data from separate platforms. Conventional high-throughput…
Mission Bio
Single cell Sequencing

Violet 3.0 & QF-Pro® Technology

Conventional spatial biology reveals where proteins are; Violet 3.0 and QF-Pro® technology reveal what they are doing. Most current proteomic assays are limited to measuring molecular expression levels, overlooking whether proteins are actually activated or interacting with one another. In critical fields such as immuno-oncology, neurobiology and drug development, the relationship between expression and the…
Hawk Biosystem
Functional Assay

Beacon® Optofluidic Suite

The Beacon® Optofluidic Suite represents an absolute revolution in cell biology and biotherapeutic development. By synergistically integrating advanced microfluidics, precision optics, optoelectronics and artificial intelligence, this platform enables the isolation, culture, characterization and recovery of thousands of individual cells in a fully automated manner and in real time. Unlike traditional static or destructive methodologies, Bruker’s…
Bruker
Functional Assay